AU3261197A - Piperidine acetic acid derivatives and their use in the treatment of thromb otic disorders - Google Patents

Piperidine acetic acid derivatives and their use in the treatment of thromb otic disorders

Info

Publication number
AU3261197A
AU3261197A AU32611/97A AU3261197A AU3261197A AU 3261197 A AU3261197 A AU 3261197A AU 32611/97 A AU32611/97 A AU 32611/97A AU 3261197 A AU3261197 A AU 3261197A AU 3261197 A AU3261197 A AU 3261197A
Authority
AU
Australia
Prior art keywords
thromb
treatment
acetic acid
acid derivatives
otic disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32611/97A
Other languages
English (en)
Inventor
David George Allen
Colin David Eldred
Brian David Judkins
William Leonard Mitchell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9613018.2A external-priority patent/GB9613018D0/en
Priority claimed from GBGB9613017.4A external-priority patent/GB9613017D0/en
Priority claimed from GBGB9613095.0A external-priority patent/GB9613095D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU3261197A publication Critical patent/AU3261197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU32611/97A 1996-06-21 1997-06-19 Piperidine acetic acid derivatives and their use in the treatment of thromb otic disorders Abandoned AU3261197A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9613018.2A GB9613018D0 (en) 1996-06-21 1996-06-21 Therapeutic indazoles
GB9613018 1996-06-21
GBGB9613017.4A GB9613017D0 (en) 1996-06-21 1996-06-21 Therapeutic compounds
GB9613017 1996-06-21
GBGB9613095.0A GB9613095D0 (en) 1996-06-21 1996-06-21 Therapeutic piperidines
GB9613095 1996-06-21
PCT/EP1997/003196 WO1997049699A1 (en) 1996-06-21 1997-06-19 Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders

Publications (1)

Publication Number Publication Date
AU3261197A true AU3261197A (en) 1998-01-14

Family

ID=27268341

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32611/97A Abandoned AU3261197A (en) 1996-06-21 1997-06-19 Piperidine acetic acid derivatives and their use in the treatment of thromb otic disorders

Country Status (17)

Country Link
EP (1) EP0912555A1 (no)
JP (1) JP2000512648A (no)
KR (1) KR20000022041A (no)
AP (1) AP9801417A0 (no)
AR (1) AR008245A1 (no)
AU (1) AU3261197A (no)
BR (1) BR9709930A (no)
CA (1) CA2258753A1 (no)
CZ (1) CZ424698A3 (no)
EA (1) EA199801015A1 (no)
ID (1) ID17052A (no)
IL (1) IL127464A0 (no)
IS (1) IS4924A (no)
NO (1) NO985974L (no)
PL (1) PL330797A1 (no)
TR (1) TR199802665T2 (no)
WO (1) WO1997049699A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1401831A1 (en) 2001-07-03 2004-03-31 Chiron Corporation Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors
US7642278B2 (en) 2001-07-03 2010-01-05 Novartis Vaccines And Diagnostics, Inc. Indazole benzimidazole compounds
TW200401641A (en) 2002-07-18 2004-02-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
CN100422171C (zh) * 2003-02-14 2008-10-01 惠氏公司 作为5-羟色胺-6配体的杂环-3-磺酰基吲唑
JP2009532471A (ja) 2006-04-05 2009-09-10 ワイス ５−ヒドロキシトリプタミン−６リガンドとしてのスルホニル−３−ヘテロシクリルインダゾール誘導体
EP2118062A1 (en) 2007-01-10 2009-11-18 F. Hoffmann-Roche AG Sulfonamide derivatives as chymase inhibitors
CN113655155A (zh) * 2021-07-28 2021-11-16 任贤金 一种测定sph3127有关物质的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4124942A1 (de) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0612313A1 (en) * 1991-11-14 1994-08-31 Glaxo Group Limited Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
GB9208740D0 (en) * 1992-04-23 1992-06-10 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
CA2258753A1 (en) 1997-12-31
NO985974D0 (no) 1998-12-18
EP0912555A1 (en) 1999-05-06
BR9709930A (pt) 1999-08-10
WO1997049699A1 (en) 1997-12-31
IS4924A (is) 1998-12-15
ID17052A (id) 1997-12-04
CZ424698A3 (cs) 1999-05-12
AR008245A1 (es) 1999-12-29
JP2000512648A (ja) 2000-09-26
KR20000022041A (ko) 2000-04-25
TR199802665T2 (xx) 1999-03-22
EA199801015A1 (ru) 1999-08-26
NO985974L (no) 1999-02-17
AP9801417A0 (en) 1998-12-31
PL330797A1 (en) 1999-06-07
IL127464A0 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
AU3339897A (en) Sulphonamide derivatives and their use in the treatment of cns disorders
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
AU3102097A (en) Spiro-piperidine derivatives and their use as therapeutic agents
AU2103097A (en) Cinnoline derivatives and use as medicine
AU7132998A (en) Substituted pyrrolopyridines useful in the treatment of inflammatory diseases
AU3866597A (en) Propionic acid derivatives and use thereof
AU3725997A (en) S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
AU6566094A (en) Heterocyclic derivatives in the treatment of ischaemia and related diseases
AU2160297A (en) Method for the production of activated marked tumor-specific t cells and use thereof in treatment of tumors
AU4171500A (en) Flupirtine in the treatment of fibromyalgia and related conditions
AU1732395A (en) Certain cerulenin-geranyl and dodecanoic acid derivatives
AU1886197A (en) Quinolones and their therapeutic use
AU4061597A (en) Treatment of the common cold or allergic rhinitis
AU2655097A (en) Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
AU3831295A (en) 7-substituted 4-aza cholanic acid derivatives and their use
AU5967896A (en) Peptidyl heterocycles useful in the treatment of thrombin re lated disorders
AU4161797A (en) Benzoperimidine-carboxylic acids and derivatives thereof
AU7606596A (en) The use of aliphatic carboxylic acid derivatives in ophthalmic disorders
AU5886796A (en) Peptidyl heterocycles useful in the treatment of thrombin re lateddisorders
AU3099997A (en) The use of tcet in the prophylaxis and treatment of allergies
AU3261097A (en) Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders
AU3261197A (en) Piperidine acetic acid derivatives and their use in the treatment of thromb otic disorders
AU3268197A (en) Spiro-piperidine derivatives and their use as therapeutic agents
AU3114295A (en) Methods of prognosing the course and degree of dementia in patients with beta-amyloid-related diseases
AU2548795A (en) Antithrombin agents in treatment of asthma

Legal Events

Date Code Title Description
MK3 Application lapsed section 142(2)(c) - examination deferred under section 46 no request for examination